Zonisamide Capsule
Product Images NDC 68001-244

5 FDA label images from Bluepoint Laboratories · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zonisamide (NDC 68001-244). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Formula Of Zonisamide (345efcc4 6a36 4ddf 8b6c 9c6c844dab0a 01)

Chemical Formula Of Zonisamide (345efcc4 6a36 4ddf 8b6c 9c6c844dab0a 01)
Chemical structure of zonisamide, showing a benzisoxazole ring fused with a methylsulfonamide group. The diagram depicts the molecular framework of the active ingredient zonisamide.*
FDA Label Image

Figure 1: Proportion Of Patients Achieving Differing Levels Of Seizure Reduction In Zonisamide And Placebo Groups In Studies 2 And 3 (345efcc4 6a36 4ddf 8b6c 9c6c844dab0a 02)

Figure 1: Proportion Of Patients Achieving Differing Levels Of Seizure Reduction In Zonisamide And Placebo Groups In Studies 2 And 3 (345efcc4 6a36 4ddf 8b6c 9c6c844dab0a 02)
A line graph comparing the percentage reduction in all partial seizures rate between two treatment arms: Zonisamide and Placebo. The x-axis represents the percentage of patients, decreasing from 100 to 0, while the y-axis shows the percent reduction in seizures, ranging from -530 to 100. An annotation on the right side indicates the direction for improvement and worsening in seizure rates.*
FDA Label Image

Zonisamide Capsules 100mg 100 Capsules Rev 03-17 (Zonisamide Capsules 100mg 100 Capsules Rev 0714)

Zonisamide Capsules 100mg 100 Capsules Rev 03-17 (Zonisamide Capsules 100mg 100 Capsules Rev 0714)
Zonisamide Capsule, USP 100 mg oral capsules label shows the product name, dosage strength, and form. Manufactured by Glenmark Pharmaceuticals Ltd for BluePoint Laboratories, it contains 100 capsules. The label includes storage instructions, a barcode, and pharmacist dispensing guidance, with the NDC 68001-244-00.*
FDA Label Image

Zonisamide Capsules 25mg 100 Capsules Rev 03-17 (Zonisamide Capsules 25mg 100 Capsules Rev 0714)

Zonisamide Capsules 25mg 100 Capsules Rev 03-17 (Zonisamide Capsules 25mg 100 Capsules Rev 0714)
Zonisamide Capsule, USP 25 mg oral capsules label showing 100 capsules per package. The label includes storage instructions, dosage advisory, and a barcode. Manufactured by Glenmark Pharmaceuticals Ltd. for BluePoint Laboratories, the label advises dispensing a medication guide to each patient.*
FDA Label Image

Zonisamide Capsules 50mg 100 Capsules Rev 03-17 (Zonisamide Capsules 50mg 100 Capsules Rev 0714)

Zonisamide Capsules 50mg 100 Capsules Rev 03-17 (Zonisamide Capsules 50mg 100 Capsules Rev 0714)
Label for Zonisamide Capsule, USP 50 mg oral capsules by BluePoint Laboratories. The label states the product as prescription only with a package size of 100 capsules. It includes storage instructions, pharmacist dispensing guidance, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.